Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-04-25 4:48 pm Purchase | 13G | Century Therapeutics Inc. IPSC | Bain Capital Life Sciences Opportunities III LP | 5,320,331 6.6% | 5,320,331 (New Position) | View |
2024-04-22 7:24 pm Purchase | 13G | Century Therapeutics Inc. IPSC | Boxer Capital LLC | 4,901,603 5.8% | 4,901,603 (New Position) | View |
2024-04-18 4:36 pm Purchase | 13G | Century Therapeutics Inc. IPSC | Casdin Capital LLC | 5,190,506 6.08% | 1,984,126 (+61.88%) | View |
2024-04-08 9:03 pm Sale | 13D | Century Therapeutics Inc. IPSC | Casdin Capital LLC | 3,206,380 4.95% | -16,560 (-0.51%) | View |
2024-03-04 4:16 pm Purchase | 13G | Century Therapeutics Inc. IPSC | Venrock Healthcare Capital Partners III L.P. | 3,405,133 5.4% | 3,405,133 (New Position) | View |
2024-02-09 08:50 am Sale | 13G | Century Therapeutics Inc. IPSC | FMR LLC | 3,612,551 6.037% | -210,714 (-5.51%) | View |
2024-02-08 5:35 pm Unchanged | 13G | Century Therapeutics Inc. IPSC | Versant Venture Capital VI L.P. | 11,452,014 19.1% | 0 (Unchanged) | View |
2023-11-13 09:02 am Sale | 13G | Century Therapeutics Inc. IPSC | FMR LLC | 3,823,265 6.397% | -3,273,146 (-46.12%) | View |
2023-02-09 4:19 pm Sale | 13G | Century Therapeutics Inc. IPSC | Versant Venture Capital VI L.P. | 11,452,014 19.4% | -914,800 (-7.40%) | View |
2023-02-09 09:59 am Sale | 13G | Century Therapeutics Inc. IPSC | FMR LLC | 7,096,411 12.033% | -1,099,792 (-13.42%) | View |
2022-10-11 2:09 pm Sale | 13D | Century Therapeutics Inc. IPSC | Casdin Capital LLC | 3,222,940 5.5% | -23,184 (-0.71%) | View |
2022-02-11 4:35 pm Purchase | 13G | Century Therapeutics Inc. IPSC | BAYER AKTIENGESELLSCHAFT | 12,675,838 23.2% | 12,675,838 (New Position) | View |
2022-02-11 4:30 pm Purchase | 13G | Century Therapeutics Inc. IPSC | FUJIFILM Cellular Dynamics Inc. | 6,955,207 12.7% | 6,955,207 (New Position) | View |
2022-02-10 8:39 pm Purchase | 13G | Century Therapeutics Inc. IPSC | Versant Venture Capital VI L.P. | 12,366,814 22.6% | 12,366,814 (New Position) | View |
2022-02-09 09:11 am Purchase | 13G | Century Therapeutics Inc. IPSC | FMR LLC | 8,196,203 14.999% | 943,642 (+13.01%) | View |
2021-08-10 10:33 am Purchase | 13G | Century Therapeutics Inc. IPSC | FMR LLC | 7,252,561 12.857% | 7,252,561 (New Position) | View |
2021-07-29 2:11 pm Purchase | 13D | Century Therapeutics Inc. IPSC | Casdin Capital LLC | 3,246,124 5.9% | 3,246,124 (New Position) | View |